Sedatif ve Hipnotik İlaç Zehirlenmeleri

Authors

Cansu Doğan

Synopsis

Sedatif ve hipnotik ilaçlar; anksiyete, uyku bozuklukları, anestezi ve nöbet tedavisinde yaygın olarak kullanılan merkezi sinir sistemi depresanlarıdır. Kimyasal yapılarına göre bitkisel, inorganik, organik bileşikler (özellikle barbitüratlar ve benzodiazepinler) ile endojen maddeler olarak sınıflandırılırlar. Yüksek lipofilik özellikleri sayesinde kan-beyin bariyerini hızla geçerek santral sinir sistemini etkiler ve çoğunlukla karaciğerde metabolize edilerek idrar yoluyla atılırlar. Klinik kullanımda ve toksisite vakalarında en sık öne çıkan barbitüratlar ve benzodiazepinler, özellikle suisidal girişimler ve ilaç kötüye kullanımı nedeniyle acil servis başvurularının önemli nedenlerindendir. Doza bağımlı olarak sedasyondan komaya, solunum ve dolaşım depresyonuna kadar uzanan ciddi klinik tablolara yol açabilirler. Opioid ve alkol ile kombine kullanımları mortalite riskini önemli ölçüde artırmaktadır. Barbitürat zehirlenmelerinde destekleyici tedavi, aktif kömür ve gerekli vakalarda hemodiyaliz ön plana çıkarken, bu ilaçların etkileri flumazenil ile geri döndürülemez. Benzodiazepin zehirlenmelerinde ise flumazenil yarışmacı bir antagonist olarak kullanılabilir ancak kronik kullanım, nöbet riski ve kafa içi basınç artışı gibi durumlarda kontrendikedir. Ayrıca buspiron, kloral hidrat, GHB ve Z-grubu ilaçlar gibi benzodiazepin dışı sedatiflerin de kendilerine özgü ciddi toksisite profilleri bulunmaktadır. Tanı çoğunlukla maruziyet öyküsü ve klinik muayeneye dayanmakta olup, tedavinin temelini hava yolu güvenliği, dolaşım desteği ve hastanın stabilizasyonunu sağlayan semptomatik yaklaşımlar oluşturmaktadır.

Sedative and hypnotic drugs are central nervous system depressants widely used in the treatment of anxiety, sleep disorders, anesthesia, and seizures. They are classified based on their chemical structure into herbal, inorganic, and organic compounds (especially barbiturates and benzodiazepines), as well as endogenous substances. Thanks to their high lipophilicity, they rapidly cross the blood-brain barrier to affect the central nervous system and are mostly metabolized in the liver and excreted via urine. Barbiturates and benzodiazepines, which are most prominent in clinical use and toxicity cases, are major causes of emergency department admissions, particularly due to suicidal attempts and drug abuse. Dose-dependently, they can lead to severe clinical conditions ranging from sedation to coma, as well as respiratory and cardiovascular depression. Their combined use with opioids and alcohol significantly increases the mortality risk. While supportive care, activated charcoal, and hemodialysis in necessary cases come to the fore in barbiturate poisonings, the effects of these drugs cannot be reversed with flumazenil. In benzodiazepine poisonings, flumazenil can be used as a competitive antagonist; however, it is contraindicated in conditions such as chronic use, seizure risk, and increased intracranial pressure. In addition, non-benzodiazepine sedatives such as buspirone, chloral hydrate, GHB, and Z-drugs have their own distinct and severe toxicity profiles. Diagnosis is mostly based on exposure history and clinical examination, and the foundation of treatment consists of symptomatic approaches that ensure airway safety, circulatory support, and patient stabilization.

References

Kripke, D.F. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Research 2018;5:918 Last updated: 16 MAY 2019 (13.12.2020 tarihinde https://f1000research.com/articles/5-918/v3 adresinden ulaşılmıştır).

Mellor-Goldman S, Olfson M, et al. Mortality following nonfatal opioid and sedative/hypnotic drug overdose. Am J Prev Med. 2020;59(1):59−67.

Barbara J, Turner M, Liang Y. Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants, and/or sedative-hypnotics: interactions with mental health disorders. J Gen Intern Med. 2015;30:1081–1096.

Cho J, Spence M.M, Niu F, et al. Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: a retrospective cohort study. J Gen Intern Med. 2020;35:696-703.

Anthony J. Trevor, Bertram G. Katzung, Marieke Kruidering-Hall (Eds.), (2015). Katzung & Trevor’s Pharmacology Examination & Board Review (11th ed., pp.186-193). New York: McGraw-Hill Education.

avensis.kocaeli.edu.tr. Hipnosedatif ilaçlar 2020. (10.12.2020 tarihinde https://avesis.kocaeli.edu.tr/resume/lessonmaterieldownload/berden?key=8888254a-1d8c-4cc4-80f7-67d102e6d2a5 adresinden ulaşılmıştır).

Palmaro A, Dupouy J, Lapeyre-Mestre M. Benzodiazepines and risk of death: Results from two large cohort studies in France and UK. Eur Neuropsychopharmacol. 2015; 25(10): 1566–77.

Chung WS, Lai CY, Lin CL, et al. Adverse Respiratory Events Associated With Hypnotics Use in Patients of Chronic Obstructive Pulmonary Disease: A Population-Based Case-Control Study. Medicine (Baltimore). 2015; 94(27): e1110.

ankara.edu.tr. Anxiolytic and hypnotic drugs 2020. (15.12.2020 tarihinde https://acikders.ankara.edu.tr/mod/resource/view.php?id=153701 adresinden ulaşılmıştır).

Carstairs, S. D, Tanen, D. A. (2015). Barbiturates poisoning. In Jeffrey J. Schaider, Roger M. Barkin, Stephen R. Hayden, Richard E. Wolfe, Adam Z. Barkin, Philip Shayne, Peter Rosen (Eds.), Rosen & Barkin’s 5-Minute Emergency Medicine Consult (5th ed. pp:127-127). Philadelphia: Wolters Kluwer Health.

Douglas E. Rollins, Donald K. Blumenthal (Eds.), (2016). WORKBOOK AND CASEBOOK For Goodman and Gilman’s The Pharmacological Basis of Therapeutics (pp.176-193) New York: McGraw-Hill Education.

Altınyazar, V (2010). Psikiyatride Sık Karşılaşılan Toksik Sendromlar. Psikiyatride Güncel Yaklaşımlar - Current Approaches in Psychiatry 2010; 2(4):532-571.

Chung WS, Lai CY, Lin CL, et al. Adverse Respiratory Events Associated With Hypnotics Use in Patients of Chronic Obstructive Pulmonary Disease: A Population-Based Case-Control Study. Medicine (Baltimore). 2015; 94(27): e1110.

Potokar J, Coupland N, Wilson S, et al. Assessment of GABA(A)benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines. Psychopharmacology (Berl) 1999; 146:180.

UPTODATE (2020). Benzodiazepine poisoning and withdrawal. (25.11.2020 tarihinde https://www.uptodate.com/contents/benzodiazepine-poisoning-and-withdrawal?search=benzodiazepines&source=search_result&selectedTitle=2~144&usage_type=default&display_rank=1 adresinden ulaşılmıştır).

Nelson, M.E. (2015). Benzodiazepine poisoning. In Jeffrey J. Schaider, Roger M. Barkin, Stephen R. Hayden, Richard E. Wolfe, Adam Z. Barkin, Philip Shayne, Peter Rosen (Eds.), Rosen & Barkin’s 5-Minute Emergency Medicine Consult (5th ed. pp:136-137). Philadelphia: Wolters Kluwer Health.

Liao KF, Lin CL, Lai SW, et al. Zolpidem Use Associated With Increased Risk of Pyogenic Liver Abscess: A Case-Control Study in Taiwan. Medicine (Baltimore). 2015; 94(32): e1302.

Downloads

Published

April 6, 2021

License

License